GlassScriptPhysician profile
Damion Y Walker
NPI 1720206105
$5,727.47
in general payments reported to CMS, 2019-2025
12 companies · $2,644 in 2025
The $2,644 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $620 · 2020: $123 · 2021: $35.52 · 2022: $187 · 2023: $578 · 2024: $1,540 · 2025: $2,644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,526 · Food and Beverage: $2,221 · Entertainment: $14.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,526.43 |
| Food and Beverage | $2,220.82 |
| Entertainment | $14.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,321.29 | 2019-2025 | Mako, Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed |
| Osiris Therapeutics INC. | $107.50 | 2019 | |
| Conmed Corporation | $98.67 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $43.00 | 2023 | Iovera |
| Novartis Pharmaceuticals Corporation | $42.25 | 2022 | |
| Ermi LLC | $21.91 | 2021 | |
| Solventum Corporation | $19.62 | 2025 | Prevena |
| Heron Therapeutics, INC. | $19.43 | 2023 | Zynrelef |
| Argentum Medical | $14.82 | 2024 | |
| Pfizer INC. | $13.61 | 2021 | |
| Smith+Nephew, INC. | $13.54 | 2025 | |
| Fx Shoulder Solutions, INC | $11.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Damion Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.